Pharma Journalist 8947 posts 0 comments

Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, announced the acquisition of ATXCo, Inc., including its core asset, PAT-409, a Phase I ready…
Read More...

Achillion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for danicopan (ACH-4471) for treatment in combination…
Read More...

IMMUNOPRECISE ANTIBODIES, an industry leader in the discovery of novel, therapeutic antibodies, announces that Talem Therapeutics, its wholly-owned subsidiary, has entered into an LOI…
Read More...

Zealand Pharma A/S announces positive results in the pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia in diabetes. Dasiglucagon is a potential first-in-class soluble…
Read More...

Aldeyra Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ADX-2191 for the prevention of proliferative vitreoretinopathy…
Read More...

Pfizer Inc. and Flatiron Health announced an expanded strategic collaboration to further integrate and increase the use of real-world data in Pfizer’s development of innovative targeted…
Read More...

The U.S. Food and Drug Administration announced the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in…
Read More...

Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Under the collaboration, the parties aim to establish at least five…
Read More...

eyeforpharma’s Marketing and Customer Innovation Europe (15-16 October) will bring together senior pharma executives across Marketing, Digital, CX, Brand, Product, IT/CRM and Business…
Read More...

NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, announced that it has entered into an exclusive license agreement with…
Read More...